SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Interim trading statement

3 Aug 2017 07:00

RNS Number : 9666M
Ebiquity PLC
03 August 2017
 

Ebiquity Plc

("the Company")

 

 

Interim trading statement

 

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces its trading statement for the 6 months ended 30 June 2017 ("the period").

 

Ebiquity's total revenues have grown by 5% over the period, with operating profit and earnings anticipated to be in line with market expectations.

 

During the period we continued to deliver against the milestones set out within our Growth Acceleration Plan. As planned, we organically expanded our Marketing Effectiveness practice into Europe and Asian markets, recruited dedicated business development staff in selected markets, and invested into internal support functions.

 

Additionally we launched the Ebiquity "Media Transparency Score" to help advertisers understand how well their business operations perform in achieving the level of media transparency they desire from their marketing activities, and "Total View Attribution" which enables clients to improve the return on investment of their media, by enabling them to understand which media channels and campaigns (both online and offline in combination) are the most effective and warrant increased investment.

 

Revenues from the Media Value Measurement ("MVM") practice achieved high single digit growth, benefitting from strong performance from our Contract Compliance business as clients are more focused on achieving media transparency. However, the performance of our US MVM business was softer than anticipated during the period, due to a lower rate of client renewals. We are in the process of strengthening our US team in response to these changing client demands.

 

The Market Intelligence ("MI") practice revenues from our platform business (Portfolio), which accounts for over 90% of MI revenue, increased over the period. We launched our Portfolio Digital service in Asia Pacific and Europe, which combined with high renewal rates, has driven a return to revenue growth. As expected, revenue from our project based reputation business declined in the first half.

 

Within the Marketing Performance Optimization ("MPO") practice our Marketing Effectiveness revenues continued to grow, most notably from our UK business. Additionally, during the first half of the year in line with our Growth Acceleration Plan we recruited Marketing Effectiveness practice leaders in Germany, France and Singapore. Performance from our US based Multi-Channel Analytics practice fell behind expectations due to organisational changes at some of our largest clients.

 

Whilst the first half of the year has been softer in the US, we anticipate stronger performance from the US MPO and MVM in the second half of the year and we are pleased that the MI practice has returned to growth following high renewal rates and new product launches. Management anticipate that full year trading will be broadly in line with market expectations.

 

The Company will release its interim report for the 6 months ended 30 June 2017 on 26 September 2017.

3 August 2017

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

 

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGRMZFGNZZ
Date   Source Headline
14th Feb 200712:49 pmRNSHolding(s) in Company
12th Feb 20077:02 amRNSMarketing Spend 2006
25th Jan 20077:11 amRNSTrading Update
11th Dec 20064:29 pmRNSTotal Voting Rights
20th Oct 20067:00 amRNSDirector/PDMR Shareholding
19th Oct 20067:44 amRNSPartnership with GroupM
18th Oct 20067:01 amRNSInterim Results
13th Oct 20069:09 amRNSIFRS Transitional Statement
2nd Oct 200610:20 amRNSHolding(s) in Company
29th Sep 20061:15 pmRNSNotice of Results
18th Jul 200610:35 amRNSHolding(s) in Company
25th May 20069:15 amRNSAdditional Listing
22nd May 20069:12 amRNSAdvertising Barometer
25th Apr 20067:03 amRNSPreliminary Results
13th Apr 20068:54 amRNSNotice of Results
6th Apr 20064:58 pmRNSNotice of Results
23rd Mar 20067:01 amRNSDirectorate Change
9th Feb 20067:01 amRNSTrading Statement
6th Feb 20069:07 amRNSAdvertising Barometer
8th Dec 200512:43 pmRNSHolding(s) in Company
17th Nov 20057:01 amRNSContract
14th Nov 20057:00 amRNSChange of Adviser
18th Oct 20057:01 amRNSInterim Results
16th Sep 20057:54 amRNSBoard: Chairman
14th Sep 20052:44 pmRNSNotice of Results
31st Aug 20054:10 pmRNSHolding(s) in Company
31st Aug 20054:06 pmRNSHolding(s) in Company
23rd Aug 20053:16 pmRNSCompletion of Acquisition
4th Aug 20054:24 pmRNSDirectors Shareholding
3rd Aug 20057:02 amRNSAcquisition & Placing
5th Jul 20057:34 amRNSAGM Statement
14th Jun 20057:00 amRNSAccess to Regional Portfolios
21st Apr 20051:04 pmRNSHolding(s) in Company
12th Apr 20057:15 amRNSShare Options
12th Apr 20057:01 amRNSFinal Results
21st Mar 200512:25 pmRNSHolding(s) in Company
15th Mar 200510:54 amRNSNotice of Results-Replacement
15th Mar 20059:28 amRNSNotice of Results
11th Mar 200512:07 pmRNSNotifiable Interest
1st Mar 20053:35 pmRNSHolding(s) in Company
16th Feb 20055:26 pmRNSHolding(s) in Company
28th Jan 20055:03 pmRNSHolding(s) in Company
26th Jan 200511:26 amRNSDirector Shareholding
24th Jan 20057:46 amRNSTrading Update
20th Jan 20056:14 pmRNSHolding(s) in Company
20th Jan 20056:14 pmRNSHolding(s) in Company
19th Jan 200511:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.